Corient Capital Partners, LLC Chimerix Inc Transaction History

Corient Capital Partners, LLC

  • $1.34 Billion
  • Q3 2022

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 04, 2020
SELL
$1.3 - $2.72 $14,003 - $29,299
-10,772 Closed
0 $0
Q3 2019

Nov 06, 2019
SELL
$1.93 - $4.21 $1,478 - $3,224
-766 Reduced 6.64%
10,772 $25,000
Q2 2019

Aug 08, 2019
BUY
$2.05 - $4.32 $332 - $699
162 Added 1.42%
11,538 $50,000
Q1 2019

May 10, 2019
BUY
$1.79 - $3.12 $20,363 - $35,493
11,376 New
11,376 $24,000

Others Institutions Holding CMRX

# of Institutions
70
Shares Held
37M
Call Options Held
52.7K
Put Options Held
130K
View Full List

About CHIMERIX INC

CMRX Quotes by TradingView
  • Ticker CMRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,622,896
  • Market Cap $78.9M
  • Description
  • Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...
More about CMRX
Track This Portfolio

Track Corient Capital Partners, LLC Portfolio

Follow Corient Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Corient Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Corient Capital Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email